Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London
· Delayed Price · Currency is GBP · Price in USD 511.39
-2.70 (-0.53%)
At close: Jun 20, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 39.98 billion as of June 23, 2025. Its market cap has decreased by -52.30% in one year.
Market Cap
39.98B
Enterprise Value
28.91B
Revenue
10.90B
Ranking
n/a
PE Ratio
11.48
Stock Price
511.39
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 39.98B, an increase of 41,499.52%. That is a compound annual growth rate of 20.09%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.14B |
| GSK plc | 56.79B |
| Haleon | 34.56B |
| Smith & Nephew | 9.45B |
| ConvaTec Group | 5.79B |
| Hikma Pharmaceuticals | 4.56B |
| HUTCHMED (China) | 1.87B |
| Indivior | 1.31B |